Knee replacement pain: can a simple injection match a nerve block?
NCT ID NCT07744503
First seen Aug 04, 2026 · Last updated Aug 06, 2026 · Updated 2 times
Summary
This trial asks whether a numbing injection directly into the knee works as well as a continuous nerve block for controlling pain after knee replacement surgery. Adults aged 18 to 90 with knee arthritis scheduled for a first knee replacement are randomly assigned to receive either the injection or the nerve block. Pain levels, knee movement, and satisfaction are measured over several days to see if the simpler injection method is a viable alternative.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Local infiltration analgesia (LIA) with local anesthetics versus continuous femoral and sciatic nerve block with ropivacaine
- What this could lead to
- If LIA works as well as a nerve block, it could offer a simpler, less invasive pain relief option after knee replacement surgery.
- What could go wrong
- This is a small, single-center trial, and results may not apply to all patients. Also, LIA might not provide the same level of pain control as a nerve block for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
78 people
The number who actually took part.
- Started
-
Jun 2025
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18 to 90 years * Primary or secondary knee osteoarthritis (gonarthrosis) * Scheduled for elective primary total knee arthroplasty (cruciate-retaining implant) * Ambulatory prior to surgery (able to walk unassisted) * American Society of Anesthesiologists (ASA) physical status I-III * Able to provide written informed consent Exclusion Criteria: * Post-traumatic knee arthropathy (trauma-related indication for surgery) * Wheelchair use / inability to ambulate preoperatively * ASA physical status IV or higher * Lack of capacity to provide informed consent (e.g., legal guardianship/procurator required) * Planned unicompartmental (hemi-) knee arthroplasty or revision surgery * Known allergy or contraindication to the study medications (ropivacaine, ketorolac, or epinephrine)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Arthroplasty, replacement, knee are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Elisabethinen Krankenhaus Klagenfurt
Klagenfurt, Carinthia, 9020, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which anesthesia gets joint replacement patients moving sooner?
- Can a special MRI match CT for spotting knee bone damage?
- Three ways to block hernia surgery pain go head to head
- Can a common bleeding drug make knee realignment surgery safer?
- One shot, new knee? gene therapy trial aims to quiet arthritis pain
- Three knee shots go Head-to-Head for lasting arthritis relief